Tax demand of Rs 4.33 crore received for AY 2024-25, company to appeal
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.8 pts more than Nifty Microcap 250 and 4.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Gufic Biosciences received a tax demand of Rs 4,33,36,680 (about Rs 4.33 crore) from the Income Tax Department for Assessment Year 2024-25, on account of disallowance of expenditure under section 143(1)(a) of the Income Tax Act. The order dated December 22, 2025 was received on January 19, 2026. The company plans to file an appeal before the Commissioner of Income Tax (Appeals) and is hopeful of a favourable outcome.
Tax demand of about Rs 4.33 crore; company plans to appeal, likely limited impact if appeal succeeds. Minor near-term negative.